Cinemark (NYSE:CNK – Get Free Report) had its price objective boosted by research analysts at Morgan Stanley from $24.00 to $26.00 in a report released on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s price target points to a potential upside of 21.67% from the company’s current price.
A number of other research firms also recently issued reports on CNK. Roth Mkm raised shares of Cinemark from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $19.00 to $26.00 in a report on Monday, June 24th. Wedbush reiterated an “outperform” rating and set a $25.00 price target on shares of Cinemark in a research note on Thursday, June 27th. Wells Fargo & Company upgraded Cinemark from an “underweight” rating to an “overweight” rating and upped their price objective for the stock from…
